Bicocca Open Archive

Logo unimib boa
TREZZI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.484
AS - Asia 2.333
EU - Europa 1.833
SA - Sud America 464
AF - Africa 71
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.271
SG - Singapore 911
IT - Italia 568
CN - Cina 470
BR - Brasile 347
HK - Hong Kong 297
DE - Germania 277
RU - Federazione Russa 272
VN - Vietnam 256
IE - Irlanda 197
CA - Canada 159
SE - Svezia 128
BD - Bangladesh 78
GB - Regno Unito 75
FR - Francia 63
IN - India 57
FI - Finlandia 48
AT - Austria 42
AR - Argentina 38
KR - Corea 35
TR - Turchia 35
ZA - Sudafrica 30
ES - Italia 29
PK - Pakistan 29
UA - Ucraina 29
MX - Messico 28
NL - Olanda 28
JP - Giappone 26
ID - Indonesia 24
PL - Polonia 22
EC - Ecuador 21
IQ - Iraq 21
PH - Filippine 16
CL - Cile 14
CO - Colombia 14
EG - Egitto 14
VE - Venezuela 14
DK - Danimarca 13
SA - Arabia Saudita 11
MA - Marocco 8
IL - Israele 7
JM - Giamaica 7
MY - Malesia 7
UZ - Uzbekistan 7
IR - Iran 6
JO - Giordania 6
LT - Lituania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
KZ - Kazakistan 4
PA - Panama 4
RO - Romania 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DZ - Algeria 3
HN - Honduras 3
LB - Libano 3
PE - Perù 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 8.183
Salva come PNG Salva come JPEG
Città #
Singapore 580
Ann Arbor 509
Ashburn 329
Hong Kong 288
San Jose 276
Chandler 196
Frankfurt am Main 195
Dublin 192
Woodbridge 168
Milan 142
Fairfield 129
Toronto 114
New York 101
Beijing 93
Wilmington 91
Dallas 88
Los Angeles 83
Ho Chi Minh City 81
The Dalles 66
Hanoi 64
Hefei 58
Chicago 56
Houston 53
Santa Clara 53
Seattle 51
Shanghai 49
Princeton 48
Rome 43
Cambridge 41
Jacksonville 40
São Paulo 38
Lissone 34
Moscow 34
Munich 33
Seoul 33
Boardman 32
Dearborn 30
Vienna 30
Lauterbourg 29
Buffalo 28
Altamura 24
Lawrence 22
Tokyo 20
Brooklyn 18
Jakarta 17
London 17
Nanjing 17
Turku 17
Warsaw 17
Council Bluffs 15
Helsinki 15
Montreal 15
Johannesburg 14
Orem 14
Nuremberg 13
Ottawa 12
Chennai 11
Da Nang 11
Lachine 11
Columbus 10
Denver 10
Phoenix 10
Rio de Janeiro 10
San Diego 10
Andover 9
Caronno Pertusella 9
Istanbul 9
Lahore 9
Mexico City 9
Alexandria 8
Bologna 8
Brasília 8
Charlotte 8
Guangzhou 8
Hangzhou 8
San Francisco 8
Washington 8
Xi'an 8
Baghdad 7
Belo Horizonte 7
Buenos Aires 7
Campinas 7
Changsha 7
Curitiba 7
Figino 7
Florence 7
Pavia 7
Quito 7
Shenyang 7
Stockholm 7
Tashkent 7
Turin 7
Boston 6
Cape Town 6
Caracas 6
Jinan 6
Karachi 6
Manchester 6
Melzo 6
Roubaix 6
Totale 5.211
Salva come PNG Salva come JPEG
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 385
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 354
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 328
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 312
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 303
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 297
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 289
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 282
Neutrophil Extracellular Traps in the Autoimmunity Context 277
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 273
Novel Therapies in Takayasu Arteritis 269
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 265
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 252
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 243
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 243
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 234
Immunology of membranous nephropathy: From animal models to humans 234
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 229
Evidence for charge-based mimicry in anti dsDNA antibody generation 228
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 216
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 215
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 214
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 209
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 206
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 203
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 199
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 194
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 192
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 188
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 184
ANCA-associated vasculitides (AAV) from the gender point of view 178
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 174
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 165
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 164
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 147
Totale 8.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 0 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20263.722 442 208 305 406 455 208 526 158 238 279 182 315
Totale 8.345